

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.93091488 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.68188226 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.64623566 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.43024821 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.99795535 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.90475735 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.84656445 |
| 8 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.80353123 |
| 9 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.73145709 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.71989130 |
| 11 | vocalization behavior (GO:0071625) | 4.56709872 |
| 12 | glutamate secretion (GO:0014047) | 4.49024249 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45425752 |
| 14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.44738164 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.28956362 |
| 16 | protein localization to synapse (GO:0035418) | 4.20785782 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.17303003 |
| 18 | exploration behavior (GO:0035640) | 4.16202448 |
| 19 | dendritic spine morphogenesis (GO:0060997) | 4.10518771 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.10374910 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.07247166 |
| 22 | long-term memory (GO:0007616) | 3.99730809 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.99240394 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97711230 |
| 25 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95173261 |
| 26 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.94203583 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.94119020 |
| 28 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.94044263 |
| 29 | positive regulation of membrane potential (GO:0045838) | 3.86243290 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84928874 |
| 31 | regulation of synaptic plasticity (GO:0048167) | 3.82646876 |
| 32 | L-amino acid import (GO:0043092) | 3.76296041 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.75187995 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67965765 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.66827610 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.64483114 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60111460 |
| 38 | regulation of ARF protein signal transduction (GO:0032012) | 3.57095513 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.53104279 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51030585 |
| 41 | neuron cell-cell adhesion (GO:0007158) | 3.51006729 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.50714040 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.49710477 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 3.48928670 |
| 45 | regulation of Rap GTPase activity (GO:0032317) | 3.48772467 |
| 46 | response to interleukin-15 (GO:0070672) | 3.46634056 |
| 47 | layer formation in cerebral cortex (GO:0021819) | 3.44565017 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.42893700 |
| 49 | regulation of dendritic spine development (GO:0060998) | 3.42134972 |
| 50 | gamma-aminobutyric acid transport (GO:0015812) | 3.41905086 |
| 51 | axon ensheathment in central nervous system (GO:0032291) | 3.40663817 |
| 52 | central nervous system myelination (GO:0022010) | 3.40663817 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37019270 |
| 54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35016809 |
| 55 | negative regulation of cell killing (GO:0031342) | 3.35016809 |
| 56 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.34731251 |
| 57 | nerve growth factor signaling pathway (GO:0038180) | 3.32980510 |
| 58 | sodium ion export (GO:0071436) | 3.32463190 |
| 59 | glycine transport (GO:0015816) | 3.31522944 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31473603 |
| 61 | neuronal ion channel clustering (GO:0045161) | 3.28013254 |
| 62 | positive regulation of Rap GTPase activity (GO:0032854) | 3.23518559 |
| 63 | regulation of ARF GTPase activity (GO:0032312) | 3.23262661 |
| 64 | synaptic vesicle endocytosis (GO:0048488) | 3.22870614 |
| 65 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.22573450 |
| 66 | chemosensory behavior (GO:0007635) | 3.20966963 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19836996 |
| 68 | dendritic spine organization (GO:0097061) | 3.19027095 |
| 69 | positive regulation of dendritic spine development (GO:0060999) | 3.14525608 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14360601 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13811569 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.12365003 |
| 73 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.11950371 |
| 74 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11051003 |
| 75 | signal complex assembly (GO:0007172) | 3.10735064 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.09107350 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08020114 |
| 78 | prepulse inhibition (GO:0060134) | 3.05554605 |
| 79 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.05446447 |
| 80 | adenosine receptor signaling pathway (GO:0001973) | 3.04892649 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02825567 |
| 82 | regulation of neurotransmitter secretion (GO:0046928) | 3.02524572 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01028785 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 3.01028785 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01028785 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01028785 |
| 87 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01028785 |
| 88 | modulation by symbiont of host immune response (GO:0052553) | 3.01028785 |
| 89 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00379985 |
| 90 | synaptic transmission, dopaminergic (GO:0001963) | 3.00282883 |
| 91 | membrane depolarization (GO:0051899) | 2.99907731 |
| 92 | adult walking behavior (GO:0007628) | 2.98932105 |
| 93 | auditory behavior (GO:0031223) | 2.98826589 |
| 94 | neurotransmitter transport (GO:0006836) | 2.96041173 |
| 95 | regulation of beta-amyloid formation (GO:1902003) | 2.95797211 |
| 96 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.95401110 |
| 97 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95350046 |
| 98 | regulation of vesicle fusion (GO:0031338) | 2.95103808 |
| 99 | learning (GO:0007612) | 2.94792560 |
| 100 | neuromuscular process controlling posture (GO:0050884) | 2.94045441 |
| 101 | regulation of synaptic transmission (GO:0050804) | 2.91561577 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.91174472 |
| 103 | negative regulation of protein oligomerization (GO:0032460) | 2.90403714 |
| 104 | vesicle transport along microtubule (GO:0047496) | 2.90114258 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 2.89238077 |
| 106 | leukocyte aggregation (GO:0070486) | 2.87691016 |
| 107 | regulation of neurotransmitter levels (GO:0001505) | 2.87361123 |
| 108 | regulation of neurotransmitter transport (GO:0051588) | 2.87117884 |
| 109 | dendrite morphogenesis (GO:0048813) | 2.86943079 |
| 110 | regulation of female receptivity (GO:0045924) | 2.86430396 |
| 111 | behavioral defense response (GO:0002209) | 2.85488524 |
| 112 | behavioral fear response (GO:0001662) | 2.85488524 |
| 113 | proline transport (GO:0015824) | 2.84518282 |
| 114 | visual learning (GO:0008542) | 2.83979032 |
| 115 | regulation of glutamate secretion (GO:0014048) | 2.83453302 |
| 116 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.82954455 |
| 117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81902252 |
| 118 | neuron recognition (GO:0008038) | 2.79720486 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.76927345 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76810194 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75219544 |
| 122 | behavioral response to cocaine (GO:0048148) | 2.75174839 |
| 123 | adaptation of signaling pathway (GO:0023058) | 2.74957124 |
| 124 | neuromuscular process (GO:0050905) | 2.74260085 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 2.73731372 |
| 126 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.73645655 |
| 127 | regulation of exocytosis (GO:0017157) | 2.64527915 |
| 128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.63544948 |
| 129 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.62649351 |
| 130 | microglial cell activation (GO:0001774) | 2.62478759 |
| 131 | activated T cell proliferation (GO:0050798) | 2.57718599 |
| 132 | detection of other organism (GO:0098543) | 2.55893938 |
| 133 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54350739 |
| 134 | detection of calcium ion (GO:0005513) | 2.50518185 |
| 135 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.49603909 |
| 136 | neutrophil activation (GO:0042119) | 2.48289018 |
| 137 | detection of bacterium (GO:0016045) | 2.47478146 |
| 138 | regulation of regulated secretory pathway (GO:1903305) | 2.44757667 |
| 139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44586637 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44586637 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.42254384 |
| 142 | cellular extravasation (GO:0045123) | 2.42227716 |
| 143 | membrane depolarization during action potential (GO:0086010) | 2.41181906 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 2.40556498 |
| 145 | macrophage activation (GO:0042116) | 2.40076182 |
| 146 | positive regulation of fibroblast migration (GO:0010763) | 2.38724126 |
| 147 | negative T cell selection (GO:0043383) | 2.38382157 |
| 148 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.37308088 |
| 149 | positive regulation of mast cell activation (GO:0033005) | 2.36816218 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.35394677 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.35349504 |
| 152 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.32627817 |
| 153 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.26104561 |
| 154 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.25501070 |
| 155 | leukocyte degranulation (GO:0043299) | 2.25112405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45195572 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.48048741 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08210690 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.06387575 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92232217 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77601295 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75833932 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67671418 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65758813 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.59500171 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.55131302 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46345614 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45777861 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42621235 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42621235 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33982827 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32771131 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32538281 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31665787 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23350188 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21583620 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13204084 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09867357 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.07558683 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04512137 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04286321 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02695794 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98679283 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.87641773 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84929953 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81638916 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.69839259 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67495636 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63275272 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58696416 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57542719 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.55620183 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54293350 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51514328 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49762583 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45906220 |
| 42 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.43478340 |
| 43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43142453 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40499944 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40277037 |
| 46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35657891 |
| 47 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33885430 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32524952 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29372251 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27800124 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25881416 |
| 52 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25523280 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.24386221 |
| 54 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24254713 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23678650 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22316509 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19447189 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19260694 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18108606 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17567546 |
| 61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17411828 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16605816 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15774821 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15374299 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15189617 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14512225 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13626176 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12338048 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11082500 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10882598 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10219745 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10179204 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09574700 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09342901 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08803324 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08302008 |
| 77 | AR_19668381_ChIP-Seq_PC3_Human | 1.06936842 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06734342 |
| 79 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.06677198 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06007944 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04646539 |
| 82 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03100794 |
| 83 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02581715 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01075998 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00720729 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00544434 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00090414 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00064799 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99302466 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98714993 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98456103 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96989659 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96560861 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95800666 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95634288 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95607496 |
| 97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95586579 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95570648 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.94433083 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94140776 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94072105 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93150249 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92710361 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92621379 |
| 105 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92411008 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92125476 |
| 107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91759344 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91583001 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90914328 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90501599 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90460779 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90214798 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89604559 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89329253 |
| 115 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88886058 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88493295 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88232292 |
| 118 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.87226709 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 0.86899705 |
| 120 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86817141 |
| 121 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86468840 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86145630 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86100947 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85971670 |
| 125 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85545107 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84052056 |
| 127 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83768795 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83571271 |
| 129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83567616 |
| 130 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83129070 |
| 131 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82836892 |
| 132 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82573035 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82089628 |
| 134 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81943844 |
| 135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81147062 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81063986 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81001537 |
| 138 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80428097 |
| 139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80390861 |
| 140 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80390861 |
| 141 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80303926 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77525205 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76417580 |
| 144 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76315079 |
| 145 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76114670 |
| 146 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.75366177 |
| 147 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.75075569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.57061303 |
| 2 | MP0003880_abnormal_central_pattern | 4.92398478 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17783415 |
| 4 | MP0002822_catalepsy | 3.92453973 |
| 5 | MP0004270_analgesia | 3.76979121 |
| 6 | MP0009745_abnormal_behavioral_response | 3.48161091 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.36748294 |
| 8 | MP0002064_seizures | 3.30580759 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.76813262 |
| 10 | MP0002272_abnormal_nervous_system | 2.68152283 |
| 11 | MP0001486_abnormal_startle_reflex | 2.65912851 |
| 12 | MP0003724_increased_susceptibility_to | 2.57102226 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.41379002 |
| 14 | MP0009046_muscle_twitch | 2.39342689 |
| 15 | MP0003329_amyloid_beta_deposits | 2.37308018 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.34907087 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.16263749 |
| 18 | MP0003195_calcinosis | 2.14407743 |
| 19 | MP0000920_abnormal_myelination | 2.09704824 |
| 20 | MP0008569_lethality_at_weaning | 2.03987698 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.01789403 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.94184108 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.85818427 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.84382290 |
| 25 | MP0003436_decreased_susceptibility_to | 1.83063374 |
| 26 | MP0002736_abnormal_nociception_after | 1.80430651 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.78862801 |
| 28 | MP0001970_abnormal_pain_threshold | 1.75104444 |
| 29 | MP0003075_altered_response_to | 1.72853165 |
| 30 | MP0004885_abnormal_endolymph | 1.72676771 |
| 31 | MP0003787_abnormal_imprinting | 1.71536439 |
| 32 | MP0003690_abnormal_glial_cell | 1.69433904 |
| 33 | MP0001790_abnormal_immune_system | 1.67709551 |
| 34 | MP0005387_immune_system_phenotype | 1.67709551 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.67134387 |
| 36 | MP0003633_abnormal_nervous_system | 1.66418326 |
| 37 | MP0005409_darkened_coat_color | 1.65687707 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.65579483 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.63841558 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.61947582 |
| 41 | MP0000685_abnormal_immune_system | 1.61700396 |
| 42 | MP0003879_abnormal_hair_cell | 1.60395372 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.57510871 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.55345961 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.55186358 |
| 46 | MP0006082_CNS_inflammation | 1.55168024 |
| 47 | MP0001800_abnormal_humoral_immune | 1.54891406 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.54033912 |
| 49 | MP0004924_abnormal_behavior | 1.54033912 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.47187865 |
| 51 | MP0000955_abnormal_spinal_cord | 1.44407608 |
| 52 | MP0001529_abnormal_vocalization | 1.44011248 |
| 53 | MP0002419_abnormal_innate_immunity | 1.43383960 |
| 54 | MP0003122_maternal_imprinting | 1.40899499 |
| 55 | MP0001905_abnormal_dopamine_level | 1.40611153 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.38235795 |
| 57 | MP0002723_abnormal_immune_serum | 1.36633315 |
| 58 | MP0000604_amyloidosis | 1.36222969 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.36193409 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.36143100 |
| 61 | MP0005025_abnormal_response_to | 1.35670379 |
| 62 | MP0003631_nervous_system_phenotype | 1.35475747 |
| 63 | MP0004510_myositis | 1.34774749 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.32698265 |
| 65 | MP0008874_decreased_physiological_sensi | 1.31239091 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.30173835 |
| 67 | MP0001819_abnormal_immune_cell | 1.27545054 |
| 68 | MP0009785_altered_susceptibility_to | 1.27013528 |
| 69 | MP0000778_abnormal_nervous_system | 1.26221539 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.25434085 |
| 71 | MP0004142_abnormal_muscle_tone | 1.23278670 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.19825836 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.16756000 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.15933113 |
| 75 | MP0002229_neurodegeneration | 1.14177149 |
| 76 | MP0002184_abnormal_innervation | 1.13319544 |
| 77 | MP0003634_abnormal_glial_cell | 1.11637997 |
| 78 | MP0004858_abnormal_nervous_system | 1.11455301 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.10490615 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.07660459 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 1.05405629 |
| 82 | MP0004742_abnormal_vestibular_system | 1.03368173 |
| 83 | MP0008872_abnormal_physiological_respon | 1.02569420 |
| 84 | MP0005310_abnormal_salivary_gland | 1.01591055 |
| 85 | MP0004381_abnormal_hair_follicle | 0.99331354 |
| 86 | MP0003763_abnormal_thymus_physiology | 0.96304415 |
| 87 | MP0001984_abnormal_olfaction | 0.95974073 |
| 88 | MP0002928_abnormal_bile_duct | 0.95184443 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.94763434 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.93833664 |
| 91 | MP0003632_abnormal_nervous_system | 0.93398332 |
| 92 | MP0005535_abnormal_body_temperature | 0.93219884 |
| 93 | MP0003123_paternal_imprinting | 0.93018178 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.92229441 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.91249345 |
| 96 | MP0002152_abnormal_brain_morphology | 0.89941165 |
| 97 | MP0000716_abnormal_immune_system | 0.88984548 |
| 98 | MP0002398_abnormal_bone_marrow | 0.85665555 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.85065457 |
| 100 | MP0001485_abnormal_pinna_reflex | 0.84102004 |
| 101 | MP0002163_abnormal_gland_morphology | 0.82068866 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.81848927 |
| 103 | MP0001944_abnormal_pancreas_morphology | 0.81677947 |
| 104 | MP0002405_respiratory_system_inflammati | 0.80894322 |
| 105 | MP0003303_peritoneal_inflammation | 0.80180592 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.79708131 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.79254843 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.79012583 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.77401065 |
| 110 | MP0005166_decreased_susceptibility_to | 0.73303791 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.72986601 |
| 112 | MP0001177_atelectasis | 0.70821673 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.67377302 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.61878145 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.61845159 |
| 116 | MP0004085_abnormal_heartbeat | 0.60746062 |
| 117 | MP0001664_abnormal_digestion | 0.59063997 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.56855546 |
| 119 | MP0004043_abnormal_pH_regulation | 0.55419371 |
| 120 | MP0003283_abnormal_digestive_organ | 0.55248242 |
| 121 | MP0006276_abnormal_autonomic_nervous | 0.53971170 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.53555469 |
| 123 | MP0002090_abnormal_vision | 0.52719121 |
| 124 | MP0003045_fibrosis | 0.52716151 |
| 125 | MP0005671_abnormal_response_to | 0.49750191 |
| 126 | MP0005551_abnormal_eye_electrophysiolog | 0.49133055 |
| 127 | MP0000747_muscle_weakness | 0.47846702 |
| 128 | MP0001188_hyperpigmentation | 0.47308596 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.45677508 |
| 130 | MP0010769_abnormal_survival | 0.45626102 |
| 131 | MP0003956_abnormal_body_size | 0.45079388 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.44788547 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.44554296 |
| 134 | MP0008877_abnormal_DNA_methylation | 0.44271602 |
| 135 | MP0010768_mortality/aging | 0.42668988 |
| 136 | MP0003866_abnormal_defecation | 0.42560671 |
| 137 | MP0002752_abnormal_somatic_nervous | 0.41933499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.28836290 |
| 2 | Myokymia (HP:0002411) | 7.21309943 |
| 3 | Focal seizures (HP:0007359) | 5.43041996 |
| 4 | Visual hallucinations (HP:0002367) | 5.04520811 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.68094437 |
| 6 | Stomatitis (HP:0010280) | 4.30089586 |
| 7 | Neurofibrillary tangles (HP:0002185) | 4.19279898 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.05241455 |
| 9 | Dysmetria (HP:0001310) | 3.90867179 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 3.77430624 |
| 11 | Papilledema (HP:0001085) | 3.69997756 |
| 12 | Ankle clonus (HP:0011448) | 3.63762243 |
| 13 | Action tremor (HP:0002345) | 3.62282644 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.57534726 |
| 15 | Atonic seizures (HP:0010819) | 3.49604054 |
| 16 | Postural instability (HP:0002172) | 3.46209472 |
| 17 | Absence seizures (HP:0002121) | 3.45941760 |
| 18 | Dialeptic seizures (HP:0011146) | 3.44704220 |
| 19 | Myositis (HP:0100614) | 3.41025839 |
| 20 | Poor eye contact (HP:0000817) | 3.37822862 |
| 21 | Optic neuritis (HP:0100653) | 3.37723768 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.37723768 |
| 23 | Spastic gait (HP:0002064) | 3.37557097 |
| 24 | Broad-based gait (HP:0002136) | 3.34922098 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.34231055 |
| 26 | Depression (HP:0000716) | 3.29224262 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.27765790 |
| 28 | Orchitis (HP:0100796) | 3.27749586 |
| 29 | Febrile seizures (HP:0002373) | 3.24424491 |
| 30 | Intention tremor (HP:0002080) | 3.24205203 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.23938258 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.22360970 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 3.19178443 |
| 34 | Abnormal social behavior (HP:0012433) | 3.13758891 |
| 35 | Impaired social interactions (HP:0000735) | 3.13758891 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.13595071 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 3.12046422 |
| 38 | Urinary urgency (HP:0000012) | 3.08066969 |
| 39 | Episodic fever (HP:0001954) | 3.04116388 |
| 40 | Truncal ataxia (HP:0002078) | 3.03427107 |
| 41 | Dysdiadochokinesis (HP:0002075) | 3.01817737 |
| 42 | Anxiety (HP:0000739) | 2.98641676 |
| 43 | Mutism (HP:0002300) | 2.95844412 |
| 44 | Scanning speech (HP:0002168) | 2.95216211 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.94277230 |
| 46 | Stereotypic behavior (HP:0000733) | 2.84198597 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84140908 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.82449259 |
| 49 | Hemiplegia (HP:0002301) | 2.81296833 |
| 50 | Impaired smooth pursuit (HP:0007772) | 2.80598312 |
| 51 | Annular pancreas (HP:0001734) | 2.79014700 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78663087 |
| 53 | Torticollis (HP:0000473) | 2.77287020 |
| 54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.74424961 |
| 55 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.74424961 |
| 56 | Abnormality of binocular vision (HP:0011514) | 2.70386794 |
| 57 | Diplopia (HP:0000651) | 2.70386794 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.68753440 |
| 59 | Peripheral hypomyelination (HP:0007182) | 2.65286101 |
| 60 | Focal dystonia (HP:0004373) | 2.64786626 |
| 61 | Hyperventilation (HP:0002883) | 2.64135051 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60226746 |
| 63 | Onion bulb formation (HP:0003383) | 2.56614716 |
| 64 | Abnormality of the corticospinal tract (HP:0002492) | 2.55172392 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.54494838 |
| 66 | Bradykinesia (HP:0002067) | 2.53589155 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.51904720 |
| 68 | Increased circulating renin level (HP:0000848) | 2.47765022 |
| 69 | Ketoacidosis (HP:0001993) | 2.47049187 |
| 70 | Meningitis (HP:0001287) | 2.46184716 |
| 71 | Recurrent skin infections (HP:0001581) | 2.45272589 |
| 72 | Slow saccadic eye movements (HP:0000514) | 2.44191791 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42476506 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42476506 |
| 75 | Abnormality of the lower motor neuron (HP:0002366) | 2.41615510 |
| 76 | Genetic anticipation (HP:0003743) | 2.41066501 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.40989424 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.38322537 |
| 79 | Hypochromic anemia (HP:0001931) | 2.36184658 |
| 80 | Insomnia (HP:0100785) | 2.35430149 |
| 81 | Progressive inability to walk (HP:0002505) | 2.35141115 |
| 82 | Amblyopia (HP:0000646) | 2.34184805 |
| 83 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33409524 |
| 84 | Craniofacial dystonia (HP:0012179) | 2.32752615 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.31999248 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.29399013 |
| 87 | Generalized myoclonic seizures (HP:0002123) | 2.28085851 |
| 88 | Impaired vibratory sensation (HP:0002495) | 2.27932563 |
| 89 | Abnormality of saccadic eye movements (HP:0000570) | 2.25618338 |
| 90 | Encephalitis (HP:0002383) | 2.24889698 |
| 91 | Vasculitis (HP:0002633) | 2.23085418 |
| 92 | Rigidity (HP:0002063) | 2.22423751 |
| 93 | Termporal pattern (HP:0011008) | 2.22193393 |
| 94 | Insidious onset (HP:0003587) | 2.22193393 |
| 95 | Abnormality of the periventricular white matter (HP:0002518) | 2.22010498 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.20176119 |
| 97 | Pointed chin (HP:0000307) | 2.20034534 |
| 98 | Hypomagnesemia (HP:0002917) | 2.19669007 |
| 99 | Clonus (HP:0002169) | 2.19399661 |
| 100 | Epileptiform EEG discharges (HP:0011182) | 2.18807281 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 2.18262618 |
| 102 | Excessive salivation (HP:0003781) | 2.17485926 |
| 103 | Drooling (HP:0002307) | 2.17485926 |
| 104 | Megalencephaly (HP:0001355) | 2.16147000 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 2.15716674 |
| 106 | Petechiae (HP:0000967) | 2.15058416 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.14326075 |
| 108 | Macroorchidism (HP:0000053) | 2.14264148 |
| 109 | Rapidly progressive (HP:0003678) | 2.12778356 |
| 110 | Spastic tetraparesis (HP:0001285) | 2.09548230 |
| 111 | Psychosis (HP:0000709) | 2.08794816 |
| 112 | Hemiparesis (HP:0001269) | 2.08597551 |
| 113 | Hemoptysis (HP:0002105) | 2.08516321 |
| 114 | Ankyloglossia (HP:0010296) | 2.06631890 |
| 115 | Bowel incontinence (HP:0002607) | 2.06447376 |
| 116 | Obstructive lung disease (HP:0006536) | 2.06410623 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06410623 |
| 118 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05968420 |
| 119 | Dysmetric saccades (HP:0000641) | 2.05076772 |
| 120 | Ocular albinism (HP:0001107) | 2.03675849 |
| 121 | Increased CSF protein (HP:0002922) | 2.02063941 |
| 122 | Hypoglycemic seizures (HP:0002173) | 2.01802960 |
| 123 | Hypsarrhythmia (HP:0002521) | 2.00359314 |
| 124 | Agitation (HP:0000713) | 1.98893176 |
| 125 | Delusions (HP:0000746) | 1.98160304 |
| 126 | Chest pain (HP:0100749) | 1.96857659 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96711580 |
| 128 | Iris hypopigmentation (HP:0007730) | 1.93581856 |
| 129 | Panhypogammaglobulinemia (HP:0003139) | 1.92750221 |
| 130 | Resting tremor (HP:0002322) | 1.92125204 |
| 131 | Pulmonary embolism (HP:0002204) | 1.91687513 |
| 132 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91651992 |
| 133 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91651992 |
| 134 | Obstructive sleep apnea (HP:0002870) | 1.91509424 |
| 135 | Memory impairment (HP:0002354) | 1.91384939 |
| 136 | Apathy (HP:0000741) | 1.91320433 |
| 137 | Hematochezia (HP:0002573) | 1.91155154 |
| 138 | Polyphagia (HP:0002591) | 1.90272514 |
| 139 | Gait ataxia (HP:0002066) | 1.89641050 |
| 140 | Clumsiness (HP:0002312) | 1.89465350 |
| 141 | Lower limb amyotrophy (HP:0007210) | 1.88898049 |
| 142 | Absent speech (HP:0001344) | 1.86693645 |
| 143 | Thickened helices (HP:0000391) | 1.85934249 |
| 144 | Abnormal large intestine physiology (HP:0012700) | 1.85518304 |
| 145 | Akinesia (HP:0002304) | 1.84698720 |
| 146 | Abnormality of oral frenula (HP:0000190) | 1.82755051 |
| 147 | Status epilepticus (HP:0002133) | 1.82003668 |
| 148 | Widely spaced teeth (HP:0000687) | 1.81581972 |
| 149 | Pustule (HP:0200039) | 1.81454970 |
| 150 | Spontaneous hematomas (HP:0007420) | 1.80764701 |
| 151 | Large for gestational age (HP:0001520) | 1.79626062 |
| 152 | Limb dystonia (HP:0002451) | 1.78986177 |
| 153 | Inability to walk (HP:0002540) | 1.78659881 |
| 154 | Global brain atrophy (HP:0002283) | 1.78172363 |
| 155 | Polydipsia (HP:0001959) | 1.77907431 |
| 156 | Abnormal drinking behavior (HP:0030082) | 1.77907431 |
| 157 | Tetraplegia (HP:0002445) | 1.77883660 |
| 158 | Microcytic anemia (HP:0001935) | 1.74445625 |
| 159 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.70083596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.35773162 |
| 2 | NTRK3 | 4.03493046 |
| 3 | MAP3K9 | 3.42110834 |
| 4 | FRK | 3.40617769 |
| 5 | RIPK4 | 2.72758110 |
| 6 | MAP3K13 | 2.31350652 |
| 7 | DAPK2 | 2.26918599 |
| 8 | PRKD3 | 2.25229976 |
| 9 | KSR2 | 2.23380138 |
| 10 | FES | 2.09357139 |
| 11 | PRPF4B | 2.06716677 |
| 12 | PAK6 | 2.02230228 |
| 13 | SIK2 | 2.00419597 |
| 14 | MINK1 | 1.87479004 |
| 15 | CAMKK1 | 1.84757026 |
| 16 | MAP3K4 | 1.80296935 |
| 17 | CDK19 | 1.72225734 |
| 18 | NTRK1 | 1.68355674 |
| 19 | CDK5 | 1.63916857 |
| 20 | TXK | 1.61156399 |
| 21 | NTRK2 | 1.57297944 |
| 22 | TNIK | 1.54408799 |
| 23 | IRAK4 | 1.53126646 |
| 24 | UHMK1 | 1.50874591 |
| 25 | DAPK1 | 1.41921616 |
| 26 | BLK | 1.40726942 |
| 27 | TYK2 | 1.40349691 |
| 28 | MAP2K7 | 1.39655584 |
| 29 | TAOK1 | 1.31626122 |
| 30 | PRKCH | 1.29977651 |
| 31 | TYRO3 | 1.28235335 |
| 32 | MARK2 | 1.24677460 |
| 33 | KSR1 | 1.24573837 |
| 34 | OXSR1 | 1.21695646 |
| 35 | CAMK1 | 1.19048945 |
| 36 | MAP3K11 | 1.18938713 |
| 37 | PTK2B | 1.16692519 |
| 38 | MARK1 | 1.16551792 |
| 39 | MAP3K2 | 1.15876839 |
| 40 | MAP2K6 | 1.12076654 |
| 41 | JAK1 | 1.10862593 |
| 42 | MAP2K4 | 1.10763994 |
| 43 | ARAF | 1.09537220 |
| 44 | PNCK | 1.05623179 |
| 45 | MAP3K7 | 1.03358480 |
| 46 | PDK1 | 1.02987399 |
| 47 | FGFR3 | 1.02887238 |
| 48 | CLK1 | 1.02559798 |
| 49 | CAMK2B | 1.01217943 |
| 50 | CSK | 0.97680371 |
| 51 | CAMK1G | 0.96770034 |
| 52 | ALK | 0.95546601 |
| 53 | FGR | 0.94575854 |
| 54 | SGK223 | 0.94296643 |
| 55 | SGK494 | 0.94296643 |
| 56 | SIK3 | 0.94183853 |
| 57 | PDPK1 | 0.93473474 |
| 58 | TAOK3 | 0.92729573 |
| 59 | TNK2 | 0.92108282 |
| 60 | STK11 | 0.91700609 |
| 61 | MAP4K1 | 0.91449326 |
| 62 | WNK3 | 0.90867879 |
| 63 | MAP3K12 | 0.90755198 |
| 64 | RAF1 | 0.88588854 |
| 65 | CDK18 | 0.88582655 |
| 66 | JAK2 | 0.88340482 |
| 67 | ITK | 0.87614616 |
| 68 | CDK15 | 0.87492517 |
| 69 | PRKD2 | 0.87285518 |
| 70 | IKBKE | 0.86666896 |
| 71 | STK38 | 0.86397890 |
| 72 | PRKCG | 0.86143380 |
| 73 | MAP2K3 | 0.85001232 |
| 74 | STK39 | 0.83886403 |
| 75 | NEK6 | 0.83091565 |
| 76 | MAP3K1 | 0.81741207 |
| 77 | ZAP70 | 0.81666778 |
| 78 | GRK5 | 0.81525653 |
| 79 | MAP4K2 | 0.81166774 |
| 80 | BTK | 0.80846238 |
| 81 | RET | 0.80662959 |
| 82 | CDK11A | 0.79893701 |
| 83 | CAMK2A | 0.78315757 |
| 84 | FGFR2 | 0.78142914 |
| 85 | CDK14 | 0.75481011 |
| 86 | LYN | 0.75023721 |
| 87 | GRK6 | 0.74522627 |
| 88 | MAPKAPK5 | 0.73805936 |
| 89 | SYK | 0.71917978 |
| 90 | ERN1 | 0.71896954 |
| 91 | CSNK1G2 | 0.71889353 |
| 92 | HCK | 0.69987670 |
| 93 | CASK | 0.69044978 |
| 94 | FYN | 0.68172955 |
| 95 | SGK1 | 0.67470220 |
| 96 | JAK3 | 0.67393246 |
| 97 | CAMKK2 | 0.67078477 |
| 98 | LCK | 0.66365404 |
| 99 | IRAK2 | 0.66089469 |
| 100 | GRK1 | 0.65854382 |
| 101 | SGK3 | 0.64651714 |
| 102 | BMPR2 | 0.63956125 |
| 103 | MAPK13 | 0.62559726 |
| 104 | PRKCQ | 0.62548630 |
| 105 | MARK3 | 0.61720542 |
| 106 | CAMK4 | 0.60567337 |
| 107 | PKN1 | 0.60301503 |
| 108 | DMPK | 0.60064809 |
| 109 | WNK1 | 0.59632832 |
| 110 | PRKG2 | 0.58007920 |
| 111 | EPHB1 | 0.57909617 |
| 112 | IKBKB | 0.54826381 |
| 113 | ADRBK2 | 0.54782081 |
| 114 | PHKG2 | 0.52745346 |
| 115 | PHKG1 | 0.52745346 |
| 116 | CSNK1A1L | 0.52616505 |
| 117 | DYRK1A | 0.51388438 |
| 118 | YES1 | 0.50919705 |
| 119 | PLK2 | 0.48586593 |
| 120 | MAPK10 | 0.48071280 |
| 121 | TEC | 0.46468693 |
| 122 | PAK3 | 0.45430702 |
| 123 | RPS6KA3 | 0.45207387 |
| 124 | SGK2 | 0.44640440 |
| 125 | MAP3K3 | 0.44603352 |
| 126 | MAPK7 | 0.44192227 |
| 127 | NLK | 0.43278708 |
| 128 | HIPK2 | 0.42020497 |
| 129 | MAPK12 | 0.40573159 |
| 130 | CSNK1G3 | 0.39087426 |
| 131 | PINK1 | 0.38825156 |
| 132 | CAMK2D | 0.38068351 |
| 133 | PRKCZ | 0.37540273 |
| 134 | PRKD1 | 0.37166664 |
| 135 | MAP3K6 | 0.36734329 |
| 136 | ROCK2 | 0.36689938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.89151289 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.88634022 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.75427017 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.65322656 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61611409 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53920504 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.51790179 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.48586481 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41279748 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36640337 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.15891913 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08526867 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.00270576 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98827539 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94832317 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94266619 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93247741 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91695182 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.91432618 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.87389578 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.63068673 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61355573 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.60552999 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56425028 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50218722 |
| 26 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.50036492 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46071395 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45529705 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.41163840 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40113056 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38506119 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35061313 |
| 33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.31101246 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31019274 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.30364269 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30040258 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.28545082 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28094163 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27158467 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.22924186 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19687105 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15641844 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13543843 |
| 44 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11018379 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09252692 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.09164270 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07354851 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.02775337 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02142812 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01321347 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01068231 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98293223 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96324918 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96119907 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95203105 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90823234 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90406019 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88079941 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85483280 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85048229 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84974117 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83138105 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82116947 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.81982986 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81754286 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81741317 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81039262 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80822241 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80171731 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79641219 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79414482 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79242504 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.78484695 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74352137 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72607701 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.71708492 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70451246 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69486258 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68201757 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67192706 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65992993 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64772370 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63644993 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63270315 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63147688 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61835498 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61487742 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61175735 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60476412 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.59251368 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.58693504 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58521398 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58067339 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57667526 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.57023985 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54353732 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53230900 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52875998 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.51668886 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49297526 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48919827 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.48276725 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48223413 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.43902220 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42142646 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42006995 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41807098 |
| 108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40864395 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.40580387 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39623581 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39118726 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37591935 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33939139 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.33894470 |
| 115 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33082824 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.29991787 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.29723619 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29114296 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.28998183 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26029926 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25610588 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25506698 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25214117 |

